196 related articles for article (PubMed ID: 15381063)
1. Identification and purification of resveratrol targeting proteins using immobilized resveratrol affinity chromatography.
Wang Z; Hsieh TC; Zhang Z; Ma Y; Wu JM
Biochem Biophys Res Commun; 2004 Oct; 323(3):743-9. PubMed ID: 15381063
[TBL] [Abstract][Full Text] [Related]
2. Identification of glutathione sulfotransferase-pi (GSTP1) as a new resveratrol targeting protein (RTP) and studies of resveratrol-responsive protein changes by resveratrol affinity chromatography.
Hsieh TC; Wang Z; Deng H; Wu JM
Anticancer Res; 2008; 28(1A):29-36. PubMed ID: 18383821
[TBL] [Abstract][Full Text] [Related]
3. Antiproliferative effects of resveratrol and the mediating role of resveratrol targeting protein NQO2 in androgen receptor-positive, hormone-non-responsive CWR22Rv1 cells.
Hsieh TC
Anticancer Res; 2009 Aug; 29(8):3011-7. PubMed ID: 19661309
[TBL] [Abstract][Full Text] [Related]
4. Negative regulation of quinone reductase 2 by resveratrol in cultured vascular smooth muscle cells.
Cai JB; Zhang ZH; Xu DJ; Qian ZY; Wang ZR; Huang YZ; Zou JG; Cao KJ
Clin Exp Pharmacol Physiol; 2008 Dec; 35(12):1419-25. PubMed ID: 18671725
[TBL] [Abstract][Full Text] [Related]
5. Control of stability of cyclin D1 by quinone reductase 2 in CWR22Rv1 prostate cancer cells.
Hsieh TC; Yang CJ; Lin CY; Lee YS; Wu JM
Carcinogenesis; 2012 Mar; 33(3):670-7. PubMed ID: 22266466
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of resveratrol and its naturally occurring methylether analogs on cell cycle and apoptosis in human androgen-responsive LNCaP cancer cells.
Wang TT; Schoene NW; Kim YS; Mizuno CS; Rimando AM
Mol Nutr Food Res; 2010 Mar; 54(3):335-44. PubMed ID: 20077416
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of melanoma cell proliferation by resveratrol is correlated with upregulation of quinone reductase 2 and p53.
Hsieh TC; Wang Z; Hamby CV; Wu JM
Biochem Biophys Res Commun; 2005 Aug; 334(1):223-30. PubMed ID: 15993843
[TBL] [Abstract][Full Text] [Related]
8. Identification of carbonyl reductase 1 as a resveratrol-binding protein by affinity chromatography using 4'-amino-3,5-dihydroxy-trans-stilbene.
Ito Y; Mitani T; Harada N; Isayama A; Tanimori S; Takenaka S; Nakano Y; Inui H; Yamaji R
J Nutr Sci Vitaminol (Tokyo); 2013; 59(4):358-64. PubMed ID: 24064738
[TBL] [Abstract][Full Text] [Related]
9. In silico and biochemical analyses identify quinone reductase 2 as a target of piceatannol.
Hsieh TC; Bennett DJ; Lee YS; Wu E; Wu JM
Curr Med Chem; 2013; 20(33):4195-202. PubMed ID: 23992305
[TBL] [Abstract][Full Text] [Related]
10. Biochemical and cellular evidence demonstrating AKT-1 as a binding partner for resveratrol targeting protein NQO2.
Hsieh TC; Lin CY; Bennett DJ; Wu E; Wu JM
PLoS One; 2014; 9(6):e101070. PubMed ID: 24968355
[TBL] [Abstract][Full Text] [Related]
11. Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines.
Hsieh TC; Wu JM
Exp Cell Res; 1999 May; 249(1):109-15. PubMed ID: 10328958
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol: Biological and pharmaceutical properties as anticancer molecule.
Hsieh TC; Wu JM
Biofactors; 2010; 36(5):360-9. PubMed ID: 20623546
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol and pterostilbene epigenetically restore PTEN expression by targeting oncomiRs of the miR-17 family in prostate cancer.
Dhar S; Kumar A; Rimando AM; Zhang X; Levenson AS
Oncotarget; 2015 Sep; 6(29):27214-26. PubMed ID: 26318586
[TBL] [Abstract][Full Text] [Related]
14. Uptake of resveratrol and role of resveratrol-targeting protein, quinone reductase 2, in normally cultured human prostate cells.
Hsieh TC
Asian J Androl; 2009 Nov; 11(6):653-61. PubMed ID: 19767760
[TBL] [Abstract][Full Text] [Related]
15. Antiandrogenic activity of resveratrol analogs in prostate cancer LNCaP cells.
Iguchi K; Toyama T; Ito T; Shakui T; Usui S; Oyama M; Iinuma M; Hirano K
J Androl; 2012; 33(6):1208-15. PubMed ID: 22700762
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic potential of resveratrol and analogs in preclinical models of prostate cancer.
Kumar A; Dhar S; Rimando AM; Lage JM; Lewin JR; Zhang X; Levenson AS
Ann N Y Acad Sci; 2015 Aug; 1348(1):1-9. PubMed ID: 26214308
[TBL] [Abstract][Full Text] [Related]
17. [Identification of AGR2 protein, a novel potential cancer marker, using proteomics technologies].
Kovalev LI; Shishkin SS; Khasigov PZ; Dzeranov NK; Kazachenko AV; Toropygin IIu; Mamykina SV
Prikl Biokhim Mikrobiol; 2006; 42(4):480-4. PubMed ID: 17022460
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell lines.
Wang Y; Romigh T; He X; Orloff MS; Silverman RH; Heston WD; Eng C
Hum Mol Genet; 2010 Nov; 19(22):4319-29. PubMed ID: 20729295
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3'-kinase/Akt pathway and Bcl-2 family proteins.
Aziz MH; Nihal M; Fu VX; Jarrard DF; Ahmad N
Mol Cancer Ther; 2006 May; 5(5):1335-41. PubMed ID: 16731767
[TBL] [Abstract][Full Text] [Related]
20. SELDI protein profiling of dunning R-3327 derived cell lines: identification of molecular markers of prostate cancer progression.
Malik G; Rojahn E; Ward MD; Gretzer MB; Partin AW; Semmes OJ; Veltri RW
Prostate; 2007 Oct; 67(14):1565-75. PubMed ID: 17705230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
